Drugs / 3 cycles chemotherapy instead of 6 cycles chemotherapy
3 cycles chemotherapy instead of 6 cycles chemotherapy
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05460000 Background | Oct 2024 → Oct 2032 expected | fallopian tube cancer, ovarian clear cell adenocarcinoma, primary peritoneal carcinoma | North Eastern German Society of Gynaecological Oncology | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3 cycles chemotherapy instead of 6 cycles chemotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05460000 ↗ |
| Action | Inhibit | “the PARP inhibitor niraparib” PMID 42140839 ↗ May 2026 |